19 September 2025 : Clinical Research
Comparative Study of Ultrasound-Guided Corticosteroid Injection with Acupotomy Release Versus Injection Alone in Carpal Tunnel Syndrome: A Randomized Controlled Trial
Song Tao CDEF 1, Shiheng Xu BF 2, Dantao Chu B 3, Chenglin Zhu C 1, Yanguan Bao AFG 4*DOI: 10.12659/MSM.948970
Med Sci Monit 2025; 31:e948970
Table 2 Clinical outcomes at baseline and 2 weeks, 1 month, and 3 months after treatment.
| Parameter | Group A (n=34) | Difference from baseline | Group B (n=34) | Difference from baseline | Inter-groupP value |
|---|---|---|---|---|---|
| Baseline | 25.76±4.17a | 24.50±4.50a | |||
| 2 wk after tx | 18.82±3.57a | −6.94±3.03 | 18.12±3.09a | −6.38±5.59 | 0.610 |
| 1 mo after tx | 17.26±3.45b | −8.50±4.83 | 19.00±4.01b | −5.50±5.24 | 0.017 |
| 3 mo after tx | 17.47±3.31c | −8.29±4.83 | 20.85±3.99c | −3.65±4.45 | 0.000 |
| Baseline | 12.26±3.67a | 11.91±3.37a | |||
| 2 wk after tx | 11.50±3.42a | −0.76±1.07 | 11.12±2.85a | −0.79±0.98 | 0.906 |
| 1 mo after tx | 10.91±3.44b | −1.35±1.35 | 11.15±2.96b | −0.76±0.92 | 0.039 |
| 3 mo after tx | 10.35±3.21c | −1.91±1.52 | 11.24±2.84c | −0.68±1.12 | 0.000 |
| Baseline | 15.31±2.96a | 14.33±2.41a | |||
| 3 mo after tx | 11.63±2.80a | −3.68±3.22 | 12.58±2.16a | −1.75±2.68 | 0.009 |
| Baseline | 3.57±0.54a | 3.49±0.45 | |||
| 3 mo after tx | 3.30±0.45a | −0.27±0.37 | 3.42±0.39 | −0.06±0.43 | 0.038 |
| BCTQ-S – Boston Carpal Tunnel Questionnaire-Symptom Severity Score; BCTQ-F – Boston Carpal Tunnel Questionnaire-Functional Status Scale; CSA – cross-sectional area; tx – treatment; wk – week; mo – month. Significant differences within the same group: a between baseline and 2-week post-tx scores; b between baseline and 1-month post-tx scores; c between baseline and 3-month post-tx scores; d between 2-week and 1-month post-tx scores; e between 2-week and 3-month post-tx scores; F between 1-month and 3-month post-tx scores. | |||||






